Loading…
Dedifferentiated chondrosarcoma: use of MRI to guide needle biopsy
AIM: To describe the use of MRI to identify and biopsy areas of dedifferentiation in patients with a suspected diagnosis of dedifferentiated chondrosarcoma. MATERIALS AND METHODS: Low-grade chondrosarcoma is characterized at magnetic resonance imaging (MRI) as having a lobulate, hyperintense appeara...
Saved in:
Published in: | Clinical radiology 2004-03, Vol.59 (3), p.268-272 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | AIM: To describe the use of MRI to identify and biopsy areas of dedifferentiation in patients with a suspected diagnosis of dedifferentiated chondrosarcoma.
MATERIALS AND METHODS: Low-grade chondrosarcoma is characterized at magnetic resonance imaging (MRI) as having a lobulate, hyperintense appearance on T2-weighted spin-echo sequences. T2-weighted MR images were assessed in 15 patients with a final pathological diagnosis of dedifferentiated chondrosarcoma for regions of atypical reduced signal intensity. Information regarding the site of ultrasound or computed tomography (CT)-guided biopsy was available in 10 cases.
RESULTS: Nine patients were male and six female with a mean age of 60 years (range 25–77 years). The sites involved were the distal femur (
n=4), pelvis (
n=3), proximal femur (
n=4), femoral diaphysis (
n=1), proximal humerus (
n=2) and proximal tibia (
n=1). The dedifferentiated component consisted of osteosarcoma (
n=5), malignant fibrous histiocytoma (
n=6), spindle cell sarcoma (
n=1), leiomyosarcoma (
n=1) and pleomorphic sarcoma (
n=1). In 14 of the 15 cases, areas of lower signal intensity lacking in lobulation were identified. In nine of the 10 cases, biopsy site included such areas and yielded high-grade sarcoma.
CONCLUSIONS: Dedifferentiation within chondrosarcoma may be identified on T2-weighted MRI as areas of reduced signal intensity. These areas should be the preferred site of biopsy. |
---|---|
ISSN: | 0009-9260 1365-229X |
DOI: | 10.1016/j.crad.2003.08.009 |